ALMODAWAT

Almodawat Specialized Medical Hospital Company

9594StocksTadawulHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	306.38M	336.65M	403.75M	—	—
Market Cap Growth	-25.0%	-16.6%	—	—	—
Enterprise Value	339.07M	351.13M	392.12M	—	—
Last Close Price	4.30	4.66	5.54	—	—
Valuation Multiples
PE Ratio	18.77	17.74	66.48	—	—
PS Ratio	2.39	2.76	5.35	—	—
PB Ratio	3.37	3.82	5.24	—	—
P/TBV Ratio	3.37	3.82	5.25	—	—
P/FCF Ratio	—	177.04	—	—	—
P/OCF Ratio	—	78.72	40.11	—	—
EV/Sales Ratio	2.65	2.88	5.20	—	—
EV/EBITDA Ratio	11.09	12.66	37.78	—	—
EV/EBIT Ratio	15.38	14.64	48.76	—	—
EV/FCF Ratio	—	184.65	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.39	0.37	0.21	0.23	0.28
Debt / EBITDA Ratio	1.17	1.01	1.18	0.36	0.60
Debt / FCF Ratio	—	17.08	—	0.95	3.71
Net Debt / Equity Ratio	0.36	0.23	0.01	0.23	0.23
Net Debt / EBITDA Ratio	1.25	0.73	0.06	0.38	0.53
Net Debt / FCF Ratio	-96.20	10.71	-0.07	0.92	3.11
Efficiency & Liquidity
Asset Turnover	0.88	0.88	0.77	1.05	1.03
Inventory Turnover	12.68	14.60	10.85	10.99	15.17
Quick Ratio	1.32	1.36	1.78	1.13	0.93
Current Ratio	1.51	1.52	2.03	1.31	1.11
Returns & Yields
Return on Equity (ROE)	+18.8%	+22.9%	+10.4%	+52.9%	+41.0%
Return on Assets (ROA)	+9.5%	+10.8%	+5.1%	+19.3%	+13.3%
Return on Invested Capital (ROIC)	+17.5%	+24.1%	+11.4%	+48.4%	+40.3%
Return on Capital Employed (ROCE)	+20.3%	+22.8%	+8.7%	+44.0%	+29.1%
Earnings Yield	+5.3%	+5.6%	+1.5%	—	—
FCF Yield	-0.1%	+0.6%	-2.1%	—	—
Payout Ratio	+30.6%	+15.0%	+359.8%	+50.3%	—
Buyback Yield / Dilution	+0.3%	-2.8%	-21.6%	—	—
Total Shareholder Return	+3.0%	-2.8%	-21.6%	—	—

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	306.38M	336.65M	403.75M	—	—
Market Cap Growth	-25.0%	-16.6%	—	—	—
Enterprise Value	339.07M	351.13M	392.12M	—	—
Last Close Price	4.30	4.66	5.54	—	—
Valuation Multiples
PE Ratio	18.77	17.74	66.48	—	—
PS Ratio	2.39	2.76	5.35	—	—
PB Ratio	3.37	3.82	5.24	—	—
P/TBV Ratio	3.37	3.82	5.25	—	—
P/FCF Ratio	—	177.04	—	—	—
P/OCF Ratio	—	78.72	40.11	—	—
EV/Sales Ratio	2.65	2.88	5.20	—	—
EV/EBITDA Ratio	11.09	12.66	37.78	—	—
EV/EBIT Ratio	15.38	14.64	48.76	—	—
EV/FCF Ratio	—	184.65	—	—	—
Leverage & Capital
Debt / Equity Ratio	0.39	0.37	0.21	0.23	0.28
Debt / EBITDA Ratio	1.17	1.01	1.18	0.36	0.60
Debt / FCF Ratio	—	17.08	—	0.95	3.71
Net Debt / Equity Ratio	0.36	0.23	0.01	0.23	0.23
Net Debt / EBITDA Ratio	1.25	0.73	0.06	0.38	0.53
Net Debt / FCF Ratio	-96.20	10.71	-0.07	0.92	3.11
Efficiency & Liquidity
Asset Turnover	0.88	0.88	0.77	1.05	1.03
Inventory Turnover	12.68	14.60	10.85	10.99	15.17
Quick Ratio	1.32	1.36	1.78	1.13	0.93
Current Ratio	1.51	1.52	2.03	1.31	1.11
Returns & Yields
Return on Equity (ROE)	+18.8%	+22.9%	+10.4%	+52.9%	+41.0%
Return on Assets (ROA)	+9.5%	+10.8%	+5.1%	+19.3%	+13.3%
Return on Invested Capital (ROIC)	+17.5%	+24.1%	+11.4%	+48.4%	+40.3%
Return on Capital Employed (ROCE)	+20.3%	+22.8%	+8.7%	+44.0%	+29.1%
Earnings Yield	+5.3%	+5.6%	+1.5%	—	—
FCF Yield	-0.1%	+0.6%	-2.1%	—	—
Payout Ratio	+30.6%	+15.0%	+359.8%	+50.3%	—
Buyback Yield / Dilution	+0.3%	-2.8%	-21.6%	—	—
Total Shareholder Return	+3.0%	-2.8%	-21.6%	—	—